Neoral C2 monitoring in pediatric liver transplant recipientsS. Dunn; K. Falkenstein; G. Cooney · 2001

Benefits of cyclosporine microemulsion (Neoral) C2 monitoring are sustained at 1 year in de novo liver transplant recipientsJ.R. Lake · 2001

Efficacy of C0 and C2 Monitoring in Adult Liver Transplant Recipients Treated With Neoral, Mycophenolate Mofetil, and SteroidsJ. Treckmann; A. Paul; A. Özcelik; F. Saner; M. Malagó; S. Nadalin; H. Lang; E. Malamutman; G. Gerken; C.E. Broelsch · 2007

Relationship of pharmacokinetics to clinical outcomesG.A Levy · 1999

Neoral C2 monitoring in solid organ transplantationG.A Levy · 2004

Neoral use in the liver transplant recipientG.A Levy · 2000

Strategies to prevent thrombosis in xenotransplantsG.A Levy; P Marsden; R Zhong; E.H Cole; D Grant · 1998

Neoral absorption profiling: an evolution in effectivenessP Belitsky; G.A Levy; A Johnston · 2000

Natural history of recurrent hepatitis C after liver transplantationG Malkan; A Humar; L Lilly; P.D Greig; D Grant; I.W Wanless; R Cameron; G.A Levy; M.S Cattrall · 2001

Observation of a K∗ resonance at 2088 MeVM Baubillier; I.J Bloodworth; A Burns; J.N Carney; G.F Cox; U Dore; J.B Kinson; K Knudson; F Levy; M MacDermott; P.J Negus; B.Y Oh; E Quercigh; J.M Scarr; G.A Smith; O Villalobos-Baillie; M.F Votruba; J Whitmore; R Zitoun · 1982